|
1
|
Rosenberg IH: Summary comments. Am J Clin
Nutr. 50:1231–1233. 1989. View Article : Google Scholar
|
|
2
|
Lexell J, Taylor CC and Sjostrom M: What
is the cause of the ageing atrophy? Total number, size and
proportion of different fiber types studied in whole vastus
lateralis muscle from 15to 83-year-old men. J Neurol Sci.
84:275–294. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kuzuya M: Aging-related frailty and
sarcopenia. The concepts and diagnostic criteria of frailty. Clin
Calcium. 28:1171–1176. 2018.In Japanese.
|
|
4
|
Tournadre A, Vial G, Capel F, Soubrier M
and Boirie Y: Sarcopenia. Joint Bone Spine. 86:309–314. 2019.
View Article : Google Scholar
|
|
5
|
Ciciliot S, Rossi AC, Dyar KA, Blaauw B
and Schiaffino S: Muscle type and fiber type specificity in muscle
wasting. Int J Biochem Cell Biol. 45:2191–2199. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nilwik R, Snijders T, Leenders M, Groen
BB, van Kranenburg J, Verdijk LB and van Loon LJ: The decline in
skeletal muscle mass with aging is mainly attributed to a reduction
in type II muscle fiber size. Exp Gerontol. 48:492–498. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Deschenes MR: Effects of aging on muscle
fibre type and size. Sports Med. 34:809–824. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chen LK, Woo J, Assantachai P, Auyeung TW,
Chou MY, Iijima K, Jang HC, Kang L, Kim M, Kim S, et al: Asian
Working group for sarcopenia: 2019 consensus update on sarcopenia
diagnosis and treatment. J Am Med Dir Assoc. 21:300–307.e2. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nishikawa H, Shiraki M, Hiramatsu A,
Moriya K, Hino K and Nishiguchi S: Japan Society of Hepatology
guidelines for sarcopenia in liver disease (1st edition):
Recommendation from the working group for creation of sarcopenia
assessment criteria. Hepatol Res. 46:951–963. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lim WS, Liang CK, Assantachai P, Auyeung
TW, Kang L, Lee WJ, Lim JY, Sugimoto K, Akishita M, Chia SL, et al:
COVID-19 and older people in Asia: Asian Working Group for
Sarcopenia calls to actions. Geriatr Gerontol Int. 20:547–558.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang PY, Li Y and Wang Q: Sarcopenia: An
underlying treatment target during the COVID-19 pandemic.
Nutrition. 84:1111042021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shang M, Cappellesso F, Amorim R, Serneels
J, Virga F, Eelen G, Carobbio S, Rincon MY, Maechler P, De Bock K,
et al: Macrophage-derived glutamine boosts satellite cells and
muscle regeneration. Nature. 587:626–631. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen X, Xiang L, Jia G, Liu G, Zhao H and
Huang Z: Leucine regulates slow-twitch muscle fibers expression and
mitochondrial function by Sirt1/AMPK signaling in porcine skeletal
muscle satellite cells. Anim Sci J. 90:255–263. 2019. View Article : Google Scholar
|
|
14
|
Verdijk LB, Koopman R, Schaart G, Meijer
K, Savelberg HH and van Loon LJ: Satellite cell content is
specifically reduced in type II skeletal muscle fibers in the
elderly. Am J Physiol Endocrinol Metab. 292:E151–E157. 2007.
View Article : Google Scholar
|
|
15
|
Fochi S, Giuriato G, De Simone T,
Gomez-Lira M, Tamburin S, Del Piccolo L, Schena F, Venturelli M and
Romanelli MG: Regulation of microRNAs in satellite cell renewal,
muscle function, sarcopenia and the role of exercise. Int J Mol
Sci. 21:67322020. View Article : Google Scholar :
|
|
16
|
Schiaffin S, Reggiani C and Murgia M:
Fiber type diversity in skeletal muscle explored by mass
spectrometry-based single fiber proteomics. Histol Histopathol.
35:239–246. 2020.
|
|
17
|
Wang Y and Pessin JE: Mechanisms for
fiber-type specificity of skeletal muscle atrophy. Curr Opin Clin
Nutr Metab Care. 16:243–250. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lepore E, Casola I, Dobrowolny G and
Musarò A: Neuromuscular Junction as an Entity of Nerve-Muscle
Communication. Cells. 8:9062019. View Article : Google Scholar :
|
|
19
|
Yamakawa H, Kusumoto D, Hashimoto H and
Yuasa S: Stem cell aging in skeletal muscle regeneration and
disease. Int J Mol Sci. 21:18302020. View Article : Google Scholar :
|
|
20
|
Liu L, Charville GW, Cheung TH, Yoo B,
Santos PJ, Schroeder M and Rando TA: Impaired notch signaling leads
to a decrease in p53 activity and mitotic catastrophe in aged
muscle stem cells. Cell Stem Cell. 23:544–556.e4. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Brack AS, Conboy MJ, Roy S, Lee M, Kuo CJ,
Keller C and Rando TA: Increased Wnt signaling during aging alters
muscle stem cell fate and increases fibrosis. Science. 317:807–810.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wilkinson DJ, Piasecki M and Atherton PJ:
The age-related loss of skeletal muscle mass and function:
Measurement and physiology of muscle fibre atrophy and muscle fibre
loss in humans. Ageing Res Rev. 47:123–132. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sartori R, Romanello V and Sandri M:
Mechanisms of muscle atrophy and hypertrophy: Implications in
health and disease. Nat Commun. 12:3302021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wilkinson DJ, Hossain T, Hill DS, Phillips
BE, Crossland H, Williams J, Loughna P, Churchward-Venne TA, Breen
L, Phillips SM, et al: Effects of leucine and its metabolite
β-hydroxy-β-methylbutyrate on human skeletal muscle protein
metabolism. J Physiol. 591:2911–2923. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kruse R, Petersson SJ, Christensen LL,
Kristensen JM, Sabaratnam R, Ørtenblad N, Andersen M and Højlund K:
Effect of long-term testosterone therapy on molecular regulators of
skeletal muscle mass and fibre-type distribution in aging men with
subnormal testosterone. Metabolism. 112:1543472020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
de Alcantara Borba D, da Silva Alves E,
Rosa JPP, Facundo LA, Costa CMA, Silva AC, Narciso FV, Silva A and
de Mello MT: Can IGF-1 serum levels really be changed by acute
physical exercise? A systematic review and meta-analysis. J Phys
Act Health. 17:575–584. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tan KT, Ang SJ and Tsai SY: Sarcopenia:
Tilting the balance of protein homeostasis. Proteomics.
20:e18004112020. View Article : Google Scholar
|
|
28
|
Laplante M and Sabatini DM: mTOR signaling
at a glance. J Cell Sci. 122:3589–3594. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
D'Antona G and Nisoli E: mTOR signaling as
a target of amino acid treatment of the age-related sarcopenia.
Interdiscip Top Gerontol. 37:115–141. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Giovannini S, Marzetti E, Borst SE and
Leeuwenburgh C: Modulation of GH/IGF-1 axis: Potential strategies
to counteract sarcopenia in older adults. Mech Ageing Dev.
129:593–601. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Akalu Y, Molla MD, Dessie G and Ayelign B:
physiological effect of ghrelin on body systems. Int J Endocrinol.
2020:13851382020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lu Y, Bradley JS, McCoski SR, Gonzalez JM,
Ealy AD and Johnson SE: Reduced skeletal muscle fiber size
following caloric restriction is associated with calpainmediated
proteolysis and attenuation of IGF-1 signaling. Am J Physiol Regul
Integr Comp Physiol. 312:R806–R815. 2017. View Article : Google Scholar
|
|
33
|
Matheny RW Jr, Carrigan CT, Abdalla MN,
Geddis AV, Leandry LA, Aguilar CA, Hobbs SS and Urso ML: RNA
transcript expression of IGF-I/PI3K pathway components in
regenerating skeletal muscle is sensitive to initial injury
intensity. Growth Horm IGF Res. 32:14–21. 2017. View Article : Google Scholar
|
|
34
|
Bodine SC, Stitt TN, Gonzalez M, Kline WO,
Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC,
Glass DJ and Yancopoulos GD: Akt/mTOR pathway is a crucial
regulator of skeletal muscle hypertrophy and can prevent muscle
atrophy in vivo. Nat Cell Biol. 3:1014–1019. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Rommel C, Bodine SC, Clarke BA, Rossman R,
Nunez L, Stitt TN, Yancopoulos GD and Glass DJ: Mediation of
IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and
PI(3) K/Akt/GSK3 pathways. Nat Cell Biol. 3:1009–1013. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Parkington JD, LeBrasseur NK, Siebert AP
and Fielding RA: Contraction-mediated mTOR, p70S6k, and ERK1/2
phosphorylation in aged skeletal muscle. J Appl Physiol 1985.
97:243–248. 2004.PubMed/NCBI
|
|
37
|
Gomes MD, Lecker SH, Jagoe RT, Navon A and
Goldberg AL: Atrogin-1, a muscle-specific F-box protein highly
expressed during muscle atrophy. Proc Natl Acad Sci USA.
98:14440–14445. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bodine SC, Latres E, Baumhueter S, Lai VK,
Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K,
et al: Identification of ubiquitin ligases required for skeletal
muscle atrophy. Science. 294:1704–1708. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Giresi PG, Stevenson EJ, Theilhaber J,
Koncarevic A, Parkington J, Fielding RA and Kandarian SC:
Identification of a molecular signature of sarcopenia. Physiol
Genomics. 21:253–263. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Clavel S, Coldefy AS, Kurkdjian E, Salles
J, Margaritis I and Derijard B: Atrophy-related ubiquitin ligases,
atrogin-1 and MuRF1 are up-regulated in aged rat Tibialis Anterior
muscle. Mech Ageing Dev. 127:794–801. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Burd NA, Gorissen SH and van Loon LJ:
Anabolic resistance of muscle protein synthesis with aging. Exerc
Sport Sci Rev. 41:169–73. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Marshall RN, Smeuninx B, Morgan PT and
Breen L: Nutritional strategies to offset disuse-induced skeletal
muscle atrophy and anabolic resistance in older adults: From
whole-foods to isolated ingredients. Nutrients. 12:15332020.
View Article : Google Scholar :
|
|
43
|
Wilson D, Jackson T, Sapey E and Lord JM:
Frailty and sarcopenia: The potential role of an aged immune
system. Ageing Res Rev. 36:1–10. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Lee JS, Auyeung TW, Kwok T, Lau EM, Leung
PC and Woo J: Associated factors and health impact of sarcopenia in
older Chinese men and women: A cross-sectional study. Gerontology.
53:404–410. 2008. View Article : Google Scholar
|
|
45
|
Baylis D, Bartlett DB, Patel HP and
Roberts HC: Understanding how we age: Insights into inflammaging.
Longev Healthspan. 2:82013. View Article : Google Scholar
|
|
46
|
Goodman MN: Tumor necrosis factor induces
skeletal muscle protein breakdown in rats. Am J Physiol.
260:E727–E730. 1991.PubMed/NCBI
|
|
47
|
Goodman MN: Interleukin-6 induces skeletal
muscle protein breakdown in rats. Proc Soc Exp Biol Med.
205:182–185. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ko F, Abadir P, Marx R, Westbrook R, Cooke
C, Yang H and Walston J: Impaired mitochondrial degradation by
autophagy in the skeletal muscle of the aged female interleukin 10
null mouse. Exp Gerontol. 73:23–27. 2016. View Article : Google Scholar :
|
|
49
|
Correia-Melo C, Marques FD, Anderson R,
Hewitt G, Hewitt R, Col J, Carroll BM, Miwa S, Birch J, Merz A, et
al: Mitochondria are required for pro-ageing features of the
senescent phenotype. EMBO J. 35:724–742. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sriram S, Subramanian S, Sathiakumar D,
Venkatesh R, Salerno MS, McFarlane CD, Kambadur R and Sharma M:
Modulation of reactive oxygen species in skeletal muscle by
myostatin is mediated through NF-κB. Aging Cell. 10:931–948. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Tang H, Inoki K, Brooks SV, Okazawa H, Lee
M, Wang J, Kim M, Kennedy CL, Macpherson PCD, Ji X, et al: mTORC1
underlies age-related muscle fiber damage and loss by inducing
oxidative stress and catabolism. Aging Cell. 18:e129432019.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Bodine SC and Baehr LM: Skeletal muscle
atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1. Am
J Physiol Endocrinol Metab. 307:E469–E484. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Povea-Cabello S, Oropesa-Ávila M, de la
Cruz-Ojeda P, Villanueva-Paz M, de la Mata M, Suárez-Rivero JM,
Álvarez-Córdoba M, Villalón-García I, Cotán D, Ybot-González P and
Sánchez-Alcázar JA: Dynamic reorganization of the cytoskeleton
during apoptosis: The two coffins hypothesis. Int J Mol Sci.
18:pii: E23932017. View Article : Google Scholar
|
|
54
|
Phillips T and Leeuwenburgh C: Muscle
fiber specific apoptosis and TNF-alpha signaling in sarcopenia are
attenuated by life-long calorie restriction. FASEB J. 19:668–670.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Dupont-Versteegden EE: Apoptosis in muscle
atrophy: Relevance to sarcopenia. Exp Gerontol. 40:473–481. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Wu H and Ballantyne CM: Skeletal muscle
inflammation and insulin resistance in obesity. J Clin Invest.
127:43–54. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Tornatore L, Thotakura AK, Bennett J,
Moretti M and Franzoso G: The nuclear factor kappa B signaling
pathway: Integrating metabolism with inflammation. Trends Cell
Biol. 22:557–566. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Puthucheary ZA, Rawal J, McPhail M,
Connolly B, Ratnayake G, Chan P, Hopkinson NS, Phadke R, Dew T,
Sidhu PS, et al: Acute skeletal muscle wasting in critical illness.
JAMA. 310:1591–600. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Merritt EK, Stec MJ, Thalacker-Mercer A,
Windham ST, Cross JM, Shelley DP, Craig Tuggle S, Kosek DJ, Kim JS
and Bamman MM: Heightened muscle inflammation susceptibility may
impair regenerative capacity in aging humans. J Appl Physiol.
115:937–948. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Nishikawa H, Enomoto H, Nishiguchi S and
Iijima H: Sarcopenic obesity in liver cirrhosis: Possible mechanism
and clinical impact. Int J Mol Sci. 22:19172021. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Pedersen BK and Febbraio MA: Muscles,
exercise and obesity: Skeletal muscle as a secretory organ. Nat Rev
Endocrinol. 8:457–465. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Giudice J and Taylor JM: Muscle as a
paracrine and endocrine organ. Curr Opin Pharmacol. 34:49–55. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Pedersen BK, Akerström TC, Nielsen AR and
Fischer CP: Role of myokines in exercise and metabolism. J Appl
Physiol. 103:1093–1098. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Ten Broek RW, Grefte S and Von den Hoff
JW: Regulatory factors and cell populations involved in skeletal
muscle regeneration. J Cell Physiol. 224:7–16. 2010.PubMed/NCBI
|
|
65
|
Adams GR: Invited Review:
Autocrine/paracrine IGF-I and skeletal muscle adaptation. J Appl
Physiol. 93:1159–1167. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Pedersen BK and Febbraio MA: Muscle as an
endocrine organ: Focus on muscle-derived interleukin-6. Physiol
Rev. 88:1379–406. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Tatsumi R, Anderson JE, Nevoret CJ, Halevy
O and Allen RE: HGF/SF is present in normal adult skeletal muscle
and is capable of activating satellite cells. Dev Biol.
194:114–128. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Rodgers JT, King KY, Brett JO, Cromie MJ,
Charville GW, Maguire KK, Brunson C, Mastey N, Liu L, Tsai CR, et
al: mTORC1 controls the adaptive transition of quiescent stem cells
from G0 to G(Alert). Nature. 509:393–396. 2014. View Article : Google Scholar
|
|
69
|
Clarke MS and Feeback DL: Mechanical load
induces sarcoplasmic wounding and FGF release in differentiated
human skeletal muscle cultures. Faseb J. 10:502–509. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Yablonka-Reuveni Z, Seger R and Rivera AJ:
Fibroblast growth factor promotes recruitment of skeletal muscle
satellite cells in young and old rats. J Histochem Cytochem.
47:23–42. 1999. View Article : Google Scholar
|
|
71
|
Jones NC, Tyner KJ, Nibarger L, Stanley
HM, Cornelison DD, Fedorov YV and Olwin BB: The p38alpha/beta MAPK
functions as a molecular switch to activate the quiescent satellite
cell. J Cell Biol. 169:105–116. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Jones NC, Fedorov YV, Rosenthal RS and
Olwin BB: ERK1/2 is required for myoblast proliferation but is
dispensable for muscle gene expression and cell fusion. J Cell
Physiol. 186:104–115. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Quinn LS, Anderson BG, Strait-bodey L,
Stroud AM and Argile M: Oversecretion of interleukin-15 from
skeletal muscle reduces adiposity. Am J Physiol Endocrinal Metab.
296:E191–E202. 2009. View Article : Google Scholar
|
|
74
|
Furmanczyk PS and Quinn LS: Interleukin-15
increases myosin accretion in human skeletal myogenic cultures.
Cell Biol Int. 27:845–851. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Quinn LS, Anderson BG, Drivdahl RH,
Alvarez B and Argilés JM: Overexpression of interleukin-15 induces
skeletal muscle hypertrophy in vitro: Implications for treatment of
muscle wasting disorders. Exp Cell Res. 280:55–63. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Quinn LS, Haugk KL and Damon SE:
Interleukin-15 stimulates C2 skeletal myoblast differentiation.
Biochem Biophys Res Commun. 239:6–10. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Shefer G, Rauner G, Yablonka-Reuveni Z and
Benayahu D: Reduced satellite cell numbers and myogenic capacity in
aging can be alleviated by endurance exercise. PLoS One.
5:e133072010. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Aoi W, Naito Y, Takagi T, Tanimura Y,
Takanami Y, Kawai Y, Sakuma K, Hang LP, Mizushima K, Hirai Y, et
al: A novel myokine, secreted protein acidic and rich in cysteine
(SPARC), suppresses colon tumorigenesis via regular exercise. Gut.
62:882–889. 2013. View Article : Google Scholar
|
|
79
|
McPherron AC, Lawler AM and Lee SJ:
Regulation of skeletal muscle mass in mice by a new TGF-beta super
family member. Nature. 387:83–90. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Saneyasu T, Honda K and Kamisoyama H:
Myostatin Increases Smad2 phosphorylation and atrogin-1 expression
in chick embryonic myotubes. J Poult Sci. 56:224–230. 2019.
View Article : Google Scholar
|
|
81
|
Nikooie R, Jafari-Sardoie S, Sheibani V
and Nejadvaziri Chatroudi A: Resistance training-induced muscle
hypertrophy is mediated by TGF-β1-Smad signaling pathway in male
Wistar rats. J Cell Physiol. 235:5649–5665. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Liu L, Hu R, You H, Li J, Liu Y, Li Q, Wu
X, Huang J, Cai X, Wang M and Wei L: Formononetin ameliorates
muscle atrophy by regulating myostatin-mediated PI3K/Akt/FoxO3a
pathway and satellite cell function in chronic kidney disease. J
Cell Mol Med. 25:1493–1506. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Hill M, Wernig A and Goldspink G: Muscle
satellite stem cell activation during local tissue injury and
repair. J Anat. 203:89–99. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Milan G, Dalla Nora E, Pilon C, Pagano C,
Granzotto M, Manco M, Mingrone G and Vettor R: Changes in muscle
myostatin expression in obese subjects after weight loss. J Clin
Endocrinol Metab. 89:2724–2727. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Mafi F, Biglari S, Ghardashi Afousi A and
Gaeini AA: Improvement in skeletal muscle strength and plasma
levels of follistatin and myostatin induced by an 8-week resistance
training and epicatechin supplementation in sarcopenic older
adults. J Aging Phys Act. 27:384–391. 2019. View Article : Google Scholar
|
|
86
|
Biglari S, Afousi AG, Mafi F and Shabkhiz
F: High-intensity interval training-induced hypertrophy in
gastrocnemius muscle via improved IGF-I/Akt/FoxO and myostatin/Smad
signaling pathways in rats. Physiol Int. Jul 7–2020.Epub ahead of
print. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Hill EW, McGivney BA, Rooney MF, Katz LM,
Parnell A and MacHugh DE: The contribution of myostatin (MSTN) and
additional modifying genetic loci to race distance aptitude in
Thoroughbred horses racing in different geographic regions. Equine
Vet J. 51:625–633. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
McGivney BA, Browne JA, Fonseca RG, Katz
LM, Machugh DE, Whiston R and Hill EW: MSTN genotypes in
Thoroughbred horses influence skeletal muscle gene expression and
racetrack performance. Anim Genet. 43:810–812. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Onde G, Penninx BW, Balkrishnan R, Fried
LP, Chaves PH, Williamson J, Carter C, Di Bari M, Guralnik JM and
Pahor M: Relation between use of angiotensin-converting enzyme
inhibitors and muscle strength and physical function in older
women: An observational study. Lancet. 359:926–930. 2002.
View Article : Google Scholar
|
|
90
|
Mogi M: Effect of renin-angiotensin system
on senescence. Geriatr Gerontol Int. 20:520–525. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Yoshida T, Tabony AM, Galvez S, Mitch WE,
Higashi Y, Sukhanov S and Delafontaine P: Molecular mechanisms and
signaling pathways of angiotensin II-induced muscle wasting:
Potential therapeutic targets for cardiac cachexia. Int J Biochem
Cell Biol. 45:2322–32. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
van den Beld AW, Kaufman JM, Zillikens MC,
Lamberts SWJ, Egan JM and van der Lely AJ: The physiology of
endocrine systems with ageing. Lancet Diabetes Endocrinol.
6:647–658. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Roy TA, Blackman MR, Harman SM, Tobin JD,
Schrager M and Metter EJ: Interrelationships of serum testosterone
and free testosterone index with FFM and strength in aging men. Am
J Physiol Endocrinol Metab. 283:E284–E294. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Sipila S, Narici M, Kjaer M, Pollanen E,
Atkinson RA, Hansen M and Kovanen V: Sex hormones and skeletal
muscle weakness. Biogerontology. 14:231–245. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Ikeda K, Horie-Inoue K and Inoue S:
Functions of estrogen and estrogen receptor signaling on skeletal
muscle. J Steroid Biochem Mol Biol. 191:1053752019. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Yoshimura N, Muraki S, Iidaka T, Oka H,
Horii C, Kawaguchi H, Akune T, Nakamura K and Tanaka S: Prevalence
and co-existence of locomotive syndrome, sarcopenia, and frailty:
The third survey of research on osteoarthritis/osteoporosis against
disability (ROAD) study. J Bone Miner Metab. 37:1058–1066. 2019.
View Article : Google Scholar : PubMed/NCBI
|
